John H. Rex
Direttore Tecnico/Scientifico/R&S presso F2G Ltd.
Posizioni attive di John H. Rex
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | 02/11/2016 | - | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Consulente / Consigliere | 01/11/2015 | - |
| Investitore di Private Equity | 01/11/2015 | - |
Storia della carriera di John H. Rex
Precedenti posizioni note di John H. Rex
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
AstraZeneca GmbH
 AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Corporate Officer/Principal | 01/01/2003 | 01/10/2016 |
CLSI, Inc.
 CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Direttore/Membro del Consiglio | - | - |
Formazione di John H. Rex
| Rice University | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 3 |
| Germania | 2 |
Posizioni
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
CLSI, Inc.
CLSI, Inc. Information Technology ServicesTechnology Services CLSI, Inc. provides computer support services. CLSI was acquired by Infor Global Solutions (Canada) Ltd. from TBG, Inc. on December 10, 1992. | Technology Services |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca GmbH is a German pharmaceutical company that manufactures and sells pharmaceutical drugs. The company is based in Wedel, Germany. The company was founded in 1999. The CEO is Hans Sijbesma. | Health Technology |
- Borsa valori
- Insiders
- John H. Rex
- Esperienza
